HOME >> MEDICINE >> NEWS
Could this be the end for injections?

Nightmares of doctors or dentists with oversized hypodermic needles could soon be a thing of the past. A new painless way of delivering drugs through the skin is described in the journal BMC Medicine this week and needles are not involved.

The technique, called microscission, uses a stream of gas to bombard small areas of the skin with tiny crystals of inert aluminium oxide. The sharp particles remove the rough surface-layer of the skin, and create tiny holes, known as microconduits, in the underlying layers of the skin. The crystals and loosened skin are taken away with the gas flow. The whole process takes less than 20 seconds.

Volunteers reported that the sensation they felt was like a gentle stream of air against the skin much less painful than being pricked by a needle.

The microconduits formed are invisible to the naked eye, measuring under mm in diameter and between 1/20mm and 1/5mm in depth. The width of the microconduits is defined by the size of holes punched in a mask made from polyimide film, which is placed over the skin.

The researchers, from the Harvard-MIT Division of Health Sciences and Technology, tested the technique by seeing whether they could administer a local anaesthetic to volunteers through the microconduits. After using microscission to create four microconduits within a small area, the researchers applied a pad soaked with the anaesthetic, lidocaine, to the region. Within two minutes the patch of skin was anaesthetised; the loss of feeling that the volunteers experienced demonstrated that the drug had been successfully delivered.

The research team led by Dr James Weaver observed that, "the onset of anaesthesia takes longer in microconduits deep enough to yield blood than in shallower, non-blood producing microcondits. Possibly the blood outflow impedes inflow of the externally-applied lidocaine, or the clotting blood partially obstructs the microconduit."

Deeper microconduits that yield
'"/>

Contact: Gemma Bradley
press@biomedcentral.com
44-207-323-0323
BioMed Central
18-Apr-2004


Page: 1 2

Related medicine news :

1. Could skin cells become brain cells?
2. Could autoantibodies predict future disease in healthy people?
3. Could you suffer from psychosis? The nose knows
4. Could a mandated food additive aimed at better fetal development be a risk for seniors?
5. Could an aspirin a day help keep prostate cancer away? Possibly
6. Drug blocks opioid side effects: Could improve palliative care
7. Students Show Restraint Could Cut School Bus Injuries
8. Areca (Betel) Nuts Could Damage Your Health
9. University Of Pittsburgh Researchers Identify Immune System Process That Could Halt Progress Of Cirrhosis In Humans
10. CT Scans Could Become Screening Tool For Heart Disease
11. New Contact Lens Material Could Lessen Risk Of Eye Infection

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Could this the end for injections

(Date:5/20/2013)... VA (PRWEB) May 20, 2013 Irritable ... pain, discomfort, bloating and alteration of bowel habits, and ... not function as they should. The muscles of the ... and is more likely to occur subsequent to an ... common cause of IBS flare-ups is gluten, a protein ...
(Date:5/20/2013)... NJ (PRWEB) May 20, 2013 The fourth ... the West New York, New Jersey, Middle School and was ... and the administrative staff, headed by principal Israel Rodriguez, contributed ... school students exposure to the abundant career choices that are ... all fields gave speeches, informative talks and career information to ...
(Date:5/20/2013)... The US Drug Watchdog ... transvaginal mesh failure, we are now calling the transvaginal ... ever seen for women, and the damages are literally ... huge number of US women. According to the New ... in which mesh was implanted vaginally to treat urinary ...
(Date:5/20/2013)... iGearUnlimited.com asked schools' technology directors to name ... The answers didn't surprise anyone: , 1. A rugged case ... 2. Not too bulky – need to fit in the ... that works in both vertical and horizontal orientations, 4. Trackable ... on each case, 5. Customizable – schools love to show ...
(Date:5/20/2013)... GA (PRWEB) May 20, 2013 Healing ... of their newest office on Briarcliff Road in the ... care facility includes Dr. Fidias E. De León ... therapists who will provide extensive medical services, occupational health, ... the greater Atlanta metropolitan area. They also offer a ...
Breaking Medicine News(10 mins):Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Offers improved hCG Diets With More Beneficial Nutritional Content, Possibly Offering Relief for Painful Symptoms of IBS 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Offers improved hCG Diets With More Beneficial Nutritional Content, Possibly Offering Relief for Painful Symptoms of IBS 3Health News:Robert Korwin DMD, and Susan Korwin Life Coach and Author, Present to Students at West New York Middle School Career Day 2Health News:Robert Korwin DMD, and Susan Korwin Life Coach and Author, Present to Students at West New York Middle School Career Day 3Health News:US Drug Watchdog Now Urges Transvaginal Mesh Failure Victims With Erosion To Call Them For The Names And Contacts Of The Best Women Attorneys 2Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 2Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 3Health News:Healing Heart Urgent Care Opens New Office In Atlanta 2
(Date:5/17/2013)... BOSTON , May 17, 2013  TechAtlas ... update for their competitive landscape map for the ... highlights over 90 international companies with drugs and ... addressing CKD and its sequelae. ... include: , hypertension - renal denervation ...
(Date:5/17/2013)... 17, 2013 Fuse Science, Inc. (OTCQB: DROP), ( ... is developing new, patent-pending technologies poised to redefine how consumers ... will hold a business update teleconference and webcast for shareholders ... 2013 at 4:30 PM ET. Fuse Science, ... the call and will be joined by Rubin ...
(Date:5/17/2013)... 2013  Sanofi (EURONEXT: SAN and NYSE: SNY ... JAKARTA , examining the selective JAK2 inhibitor SAR302503 ... dose groups. The primary endpoint assessed the proportion of ... data reported in previous trials, the most common adverse ... will be presented at an upcoming medical congress. ...
Breaking Medicine Technology:TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
Cached News: